EW vs XCUR · P/E 47, rev $3.39B vs $13.7M cap
Edwards Lifesciences Corp (EW) versus Exicure Inc (XCUR) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Exicure Inc (XCUR) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported XCUR revenue for 2026-06-30 was $0. Net income was -$1.1M. XCUR currently screens at market cap $13.7M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. XCUR currently screens at market cap $13.7M.
Not investment advice. Open the EW and XCUR stock pages for the full models.
Not investment advice.